Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

CARRA Data Analysis Support Grant

Childhood Arthritis and Rheumatology Research Alliance

CARRA’s mission is to conduct collaborative research to prevent, treat, and cure pediatric rheumatic diseases.
This grant mechanism is not for collecting data but rather for analyzing and publishing data that already exists. This mechanism ONLY supports the analysis of CARRA-related datasets. Any proposed work using datasets outside of CARRA are not eligible. The investigator should have the necessary data in hand at the time of the application submission.
This funding opportunity is available to researchers to support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a fixed set of tasks that will result in timely publication of results. Funds will be used for statistician effort/fee for service to support database cleaning and/or statistical analyses. Funds are not to be used for collecting additional data, investigator effort for drafting manuscripts, publication, or printing costs.
Grant Project Period Length: 1 year
Grant Funding Amount: up to $10,000 Grant Availability: Up to 4 awards
Application Deadline: Applications accepted on a rolling basis

CARRA Data Analysis Support Grant Submission Requirements:
• Data and Sample Share Approval Number
• Project Summary/Abstract (300 words max)
• Lay Summary (150 words max)
• Explanation of prior funding
• Specific Aims
• Research Plan:
1. Background
Describe/Include the following:
• Briefly describe the study, what data have been collected and the study outcome.
• Indicate if you have all the data in hand that is needed to complete this project.
• Note any collaborations and previous funding that are not located in your original data request
• Briefly justify specifically how you will utilize the funds.
2. Impact and Significance
• Explain how this project will advance CARRA’s mission under the 2023-2025 CARRA Strategic Plan.
3. Methods/Activities Describe/Include the following:
• Study population
• Study design
• Sample size

• Study sites
• Study schedule
• Primary and secondary outcomes
• Thoroughly describe the project activities and feasibility
• Methods for solving the problem and possible pitfalls
• Timeline for the project activities
4. Analysis and Statistical Plan
Describe/Include the following:
• Qualitative and quantitative analysis plan for project
• Provide justification for sample size
5. Environment
Describe/Include the following:
• Scientific environment
• Institutional support
• Physical and other resources available to complete the project
6. Dissemination & Data Sharing Plan
Describe/Include the following:
• Present a plan for sharing results of project through a variety of mediums
• Describe how/when data sets will be shared with CARRA to be available for future research. Please provide the year.
7. Sustainability Plan
• If applicable, present a plan for continuing project beyond period of award and future funding plans. Describe whether this project will be used to apply for future funding opportunities.
• If this is not applicable to your project, indicate with “N/A.”
• References (no page limit) (Download template)
• Budget Table
o The budget provided must indicate how funds are to be allocated.
o CARRA will allow up to 8% F&A (indirect) costs, and these must be incorporated into the project budget. If indirect costs are requested, total costs for this project must not exceed $10,000.
o Funds are NOT to be used to provide PI or Co-I salary support but can be used to support other personnel essential to the project.
o Effort must be specified for all personnel, even when cost-sharing.
o Salary support will be limited to a base-salary cap of $200,000 but can include payment of local fringe rates (in addition to salary cap).
o Please review CARRA’s statement of direct and indirect support.
o Other expenses should be discussed with CARRA personnel prior to application submission.
• Budget Justification:
o The budget justification provided must indicate how funds are to be allocated for each year
• NIH-formatted Biosketches for all Principal Investigator(s), Co-Principal Investigator(s), and all Co-Investigator(s) (limit 5 pages per biosketch; please combine all biosketches into one PDF with the PI(s) biosketch listed first.)
o (If applicable).
• Research Support
o List both selected ongoing and completed research projects for the past 3 years that relate specifically to these data and or related research. (Federal or non-Federal support). Please include funding amounts if possible.
• Letters of support
o Letter of support from collaborators, mentors and institution are highly recommended. No more than 2 total.
• Research Assurances
o Submit documentation of an Institutional Review Board (IRB) review. Funds will not be released until either 1) IRB approval letter or 2) IRB waiver/documentation that IRB has determined your project is exempt from IRB review is received.

• Appendix (limit 1 attachment)
o The only allowable appendix materials are:
▪ Blank data collection forms, blank survey forms, and blank questionnaire forms – or screenshots thereof
▪ Simple lists of interview questions
▪ Blank informed consent/assent forms
▪ Lists of additional key personnel or sites that do not fit in the space provided in the application sections
▪ Descriptions or drawings/figures/diagrams of data collection methods or machines/device as relevant.
o Do not include data, data compilations, lists of variables and acronyms, data analyses, publications manuals or instructions.
Review the detailed application checklist prior to submission. Applicants must use the templates provided when submitting their final applications. CARRA Staff is available to assist with the application process and to answer questions. Contact us by emailing grants@carragroup.org.
APPLICATIONS NOT FOLLOWING THESE INSTRUCTIONS WILL NOT BE CONSIDERED
Important Information for Data Analysis Support Grant Submissions
• Applications for this program are accepted on a rolling basis.
• Funds will be provided to the awardee’s institution in one payment to be used by the principal investigator according to the project budget.
• For projects requesting budget support to cover Registry and Biorepository costs, requested funds will be held by CARRA and paid directly to DCRI.
• If the PI is unable to complete the project, any unexpended balance must be returned to CARRA.
• Awardees are expected to submit an abstract and attend the CARRA Annual Meeting(s) until the project is complete/final results have been presented.
• If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 6 months. Requests for NCEs can be made up to 90 days prior, but no less than 30 days prior, to the project period end date.
• Awardees must submit a final progress report no later than 45 days after the project period end date.
• Timely provision of progress reports is required to be eligible for future CARRA-Arthritis Foundation grants.
• All awardees of CARR funding must abide by the procedures outlined in the to the current CARRA Publications and Presentation Guidelines when presenting/publishing findings from their projects. This includes submitting all abstracts and manuscripts to the CARRA Publications Committee for approval prior to submission and acknowledging the support of CARRA and the Arthritis Foundation by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA.”

Specialties

Rheumatology

Eligibility Requirements

• The project PI must be a CARRA member in good standing (up to date on membership dues and membership information (location, contact information, and membership status) is current and accurate. • The following current CARRA members are eligible to serve as Principal Investigators: • Pediatric Rheumatologists • Other Physicians and Health Care Professionals • Research professionals (research scientists, investigators, and coordinators) • Residents • Not eligible: Fellows, Medical and graduate students, Research professional members who are regulatory or data coordinators, Business and Industry Associate members, Nonprofit/Government Associate members, members of CARRA’s Board of Directors. Emeritus members are not permitted to serve as PIs but can serve as key personnel.
• Priority will be given to new and/or early investigators - within 7 years of completion of rheumatology fellowship training and at the rank of Instructor or Assistant Professor (or equivalent at your institution) but no higher

Sponsor Details

Sponsor Institute/Organizations: Childhood Arthritis and Rheumatology Research Alliance

Address: 1050 Connecticut Avenue, NW, Suite 500 Washington, DC 20036

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity